explore -WSS

explore

author：knowledge 2025-09-02 17:50:52 - browse：588

Warning sign illustration made of 0s and 1s. -- first opinion coverage from sTAT — Adobe

Big businesses poised to profit from the advance of artificial intelligence in health care are pushing back against newly proposed federal rules meant to increase oversight and fairness of AI tools used to help make decisions about patient care.

The opposition, which includes Google and Amazon as well as large health care providers, insurers, and medical software vendors, is focused on an attempt to put tighter guardrails around the use of AI by the Office of the National Coordinator for Health Information Technology.

The agency wants to require developers of electronic health records and other health software to provide users with details about the training and testing of predictive models that draw data from their systems, or are hosted within them. It also wants developers to assess and publicly disclose potential risks and create a way for clinicians and other users to report problems.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Oprah kicked off a national conversation on obesity. Let's have it

explore

WSS

A new study sees potential in DNA sequencing of infants

Steward Health Care has deal to sell doctor network to UnitedHealth

N.Y. state detects polio case, first in the U.S. since 2013

New research casts further doubt on a common procedure used with IVF

Merck drug for rare lung condition set for approval in U.S.

NIH fellows want a pay raise. Will that mean less money for grants?

hotspot

explore

explore

Moonlake's readout produced a cash windfall. Risks remain

Supreme Court mifepristone arguments center on docs' right to sue

Affirmative action in medical school literally saved lives

Study: Pain burden is higher in Black NFL players than white ones

Bright Health sells Medicare Advantage business to Molina

Readout Newsletter: Merck, Vertex, and Viking updates

Trump demands the U.S. pay no more for drugs than other countries … again

Will generative AI in health care meet the fate of IBM's Dr. Watson?

Wildfire smoke exposes gaps in outdoor worker protections

Food as medicine: Medically tailored meals may get standardized

explore

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Biden launches a new push to limit health care costs

FDA's naming rule on biosimilars has undermined competition

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Living with Fabry disease, a condition that causes chronic pain

A new study sees potential in DNA sequencing of infants

leisure time

explore

explore

focus